Patient-reported outcomes in randomised controlled trials of gynaecological cancers: Investigating methodological quality and impact on clinical decision-making

European Journal of Cancer

Volumn 50, Issue 11, 2014, Pages 1925-1941

  Efficace, Fabio ^a   Jacobs, Marc ^b   Pusic, Andrea ^c   Greimel, Elfriede ^d   Piciocchi, Alfonso ^a   Kieffer, Jacobien M ^e   Gilbert, Alexandra ^f   Fayers, Peter ^g   Blazeby, Jane ^h  

^a GIMEMA Data Center   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Clinical decision making; Clinical trials; Gynaecologic cancer; Patient reported outcomes; Quality of life

Indexed keywords

ARTICLE; CANCER SURVIVAL; CLINICAL DECISION MAKING; GYNECOLOGIC CANCER; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SYSTEMATIC REVIEW;

CLINICAL DECISION-MAKING; CLINICAL TRIALS; GYNAECOLOGIC CANCER; PATIENT-REPORTED OUTCOMES; QUALITY OF LIFE;

DECISION MAKING; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; PATIENT OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELF REPORT; TREATMENT OUTCOME;

EID: 84902250286     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.04.005     Document Type: Review

References (33)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 12 2010 2893 2917 10.1002/ijc.25516
2. K. Bergmark, E. Avall-Lundqvist, P.W. Dickman, L. Henningsohn, and G. Steineck Vaginal changes and sexuality in women with a history of cervical cancer N Engl J Med 340 18 1999 1383 1389 10.1056/NEJM199905063401802
3. E.R. Greimel, R. Winter, K.S. Kapp, and J. Haas Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study Psychooncology 18 5 2009 476 482 10.1002/pon.1426
4. M. Janda, A. Obermair, D. Cella, A.J. Crandon, and M. Trimmel Vulvar cancer patients' quality of life: a qualitative assessment Int J Gynecol Cancer 14 5 2004 875 881 10.1111/j.1048-891X.2004.14524.x
5. C.L. Barker, J.A. Routledge, D.J. Farnell, R. Swindell, and S.E. Davidson The impact of radiotherapy late effects on quality of life in gynaecological cancer patients Br J Cancer 100 10 2009 1558 1565 10.1038/sj.bjc.6605050
6. I. Vistad, S.D. Fossa, and A.A. Dahl A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer Gynecol Oncol 102 3 2006 563 572 10.1016/j.ygyno.2006.03.050 pii: S0090-8258(06)00316-7
7. E. Basch, A.P. Abernethy, and C.D. Mullins et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology J Clin Oncol 30 34 2012 4249 4255 10.1200/JCO.2012.42.5967
8. M. Calvert, J. Blazeby, D.G. Altman, D.A. Revicki, D. Moher, and M.D. Brundage Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension JAMA 309 8 2013 814 822 10.1001/jama.2013.879
9. O. Chassany, P. Sagnier, and P. Marquis et al. Patient-reported outcomes: the example of health related quality of life-a European guidance document for the improved integration of health related quality of life assessment in the drug regulatory process Drug Inf J 36 2002 209 238
10. C.L. Creutzberg, W.L. van Putten, and P.C. Koper et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma Lancet 355 9213 2000 1404 1411 pii: S0140673600021395
11. F. Efficace, A. Bottomley, and G. van Andel Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials Cancer 97 2 2003 377 388 10.1002/cncr.11065
12. L. Claassens, J. van Meerbeeck, and C. Coens et al. Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials J Clin Oncol 29 15 2011 2104 2120 10.1200/JCO.2010.32.3683
13. A. Bottomley, and P. Therasse Quality of life in patients undergoing systemic therapy for advanced breast cancer Lancet Oncol 3 10 2002 620 628 pii: S1470204502008768
14. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 7 2009 e1000097 10.1371/journal.pmed.1000097
15. F. Efficace, M. Feuerstein, and P. Fayers et al. Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making Eur Urol 2013 10.1016/j.eururo.2013.10.017 pii: S0302-2838(13)01090-7
16. M. Brundage, J. Blazeby, and D. Revicki et al. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards Qual Life Res 22 6 2013 1161 1175 10.1007/s11136-012-0252-1
17. J.P. Higgins, D.G. Altman, and P.C. Gotzsche et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2011 d5928 10.1136/bmj.d5928
18. J.E. Kurtz, M.C. Kaminsky, and A. Floquet et al. Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study Ann Oncol 22 11 2011 2417 2423 10.1093/annonc/mdr001
19. J. Alexandre, C. Brown, and D. Coeffic et al. CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial Br J Cancer 106 4 2012 633 637 10.1038/bjc.2011.593
20. M. Brundage, M. Gropp, and F. Mefti et al. Health-related quality of life in recurrent platinum-sensitive ovarian cancer - results from the CALYPSO trial Ann Oncol 23 8 2012 2020 2027 10.1093/annonc/mdr583
21. L. Gladieff, A. Ferrero, and G. De Rauglaudre et al. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial Ann Oncol 23 5 2012 1185 1189 10.1093/annonc/mdr441
22. F. Joly, I. Ray-Coquard, and M. Fabbro et al. Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial Gynecol Oncol 122 2 2011 226 232 10.1016/j.ygyno.2011.04. 019 pii: S0090-8258(11)00316-7
23. E. Pujade-Lauraine, U. Wagner, and E. Aavall-Lundqvist et al. Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse J Clin Oncol 28 20 2010 3323 3329 10.1200/JCO.2009.25.7519
24. D.K. Armstrong, B. Bundy, and L. Wenzel et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 1 2006 34 43 10.1056/NEJMoa052985
25. L.B. Wenzel, H.Q. Huang, D.K. Armstrong, J.L. Walker, and D. Cella Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 4 2007 437 443 10.1200/JCO.2006.07.3494
26. V.E. von Gruenigen, H.Q. Huang, K.M. Gil, H.E. Frasure, D.K. Armstrong, and L.B. Wenzel The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study Gynecol Oncol 124 3 2012 379 382 10.1016/j.ygyno.2011.11. 032 pii: S0090-8258(11)00950-4
27. T.C. Krivak, C. Tian, G.S. Rose, D.K. Armstrong, and G.L. Maxwell A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: an analysis of patients enrolled in GOG 172 Gynecol Oncol 115 1 2009 81 85 10.1016/j.ygyno.2009.06.021 pii: S0090-8258(09)00459-4
28. J.L. Walker, M.R. Piedmonte, and N.M. Spirtos et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 J Clin Oncol 27 32 2009 5331 5336 10.1200/JCO.2009.22.3248
29. A.B. Kornblith, H.Q. Huang, J.L. Walker, N.M. Spirtos, J. Rotmensch, and D. Cella Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study J Clin Oncol 27 32 2009 5337 5342 10.1200/JCO.2009.22.3529
30. J.L. Walker, M.R. Piedmonte, and N.M. Spirtos et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study J Clin Oncol 30 7 2012 695 700 10.1200/JCO.2011.38.8645
31. D. Osoba Translating the science of patient-reported outcomes assessment into clinical practice J Natl Cancer Inst Monogr 37 2007 5 11 10.1093/jncimonographs/lgm002
32. E. Greimel, G.B. Kristensen, and M.E. van der Burg et al. Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy Gynecol Oncol 131 2 2013 437 444 10.1016/j.ygyno.2013.08.014 pii: S0090-8258(13)01099-8
33. I. Vergote, C.G. Trope, and F. Amant et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer N Engl J Med 363 10 2010 943 953 10.1056/NEJMoa0908806